Medifast, Inc. (MED) financial statements and ratios from SEC XBRL: revenue $385.79M (TTM), net margin -4.8%, revenue growth -36.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $385.79M |
| Net Margin | -4.8% |
| Revenue Growth (YoY) | -36.0% |
| EPS Growth (YoY) | -994.7% |
| FCF Growth (YoY) | -92.7% |
| EV / EBITDA | 6.4 |
| Price / Book | 0.68 |
| Price / Sales | 0.42 |
| FCF Yield | 4.6% |
| DCF Value (model) | $120.15 |
| DCF Upside vs Price | 903.8% |
| Altman Z-Score | 4.64 (safe) |
| Sector P/E (Consumer Staples) | 26.7 |
MED overview · MED earnings · MED KPIs · MED investor relations · MED ownership · MED peers · MED filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.